These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


300 related items for PubMed ID: 3669156

  • 1. The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment.
    Peña JC, Monforte MF, Briceño A.
    J Urol; 1987 Nov; 138(5):1137-40. PubMed ID: 3669156
    [Abstract] [Full Text] [Related]

  • 2. Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine.
    Woelfel A, Kaplan RA, Pak CY.
    Metabolism; 1977 Feb; 26(2):201-5. PubMed ID: 834153
    [Abstract] [Full Text] [Related]

  • 3. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.
    Favus MJ, Coe FL.
    Scand J Urol Nephrol Suppl; 1980 Feb; 53():265-71. PubMed ID: 6938003
    [Abstract] [Full Text] [Related]

  • 4. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY, Sakhaee K, Fuller CJ.
    Trans Assoc Am Physicians; 1983 Feb; 96():294-305. PubMed ID: 6679957
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL, Hibberd CM, Mazzachi BC, Marshall VR.
    Clin Chim Acta; 1986 Jan 15; 154(1):59-67. PubMed ID: 3943225
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Absorptive hyperoxaluria: a new clinical entity--successful treatment with hydrochlorothiazide.
    Yendt ER, Cohanim M.
    Clin Invest Med; 1986 Jan 15; 9(1):44-50. PubMed ID: 3955921
    [Abstract] [Full Text] [Related]

  • 11. Urinary excretion of oxalate by patients with renal hypercalciuric stone disease. Effect of chronic treatment with hydrochlorothiazide.
    Urivetzky M, Braverman S, Motola JA, Smith AD.
    Urology; 1991 Apr 15; 37(4):327-30. PubMed ID: 2014597
    [Abstract] [Full Text] [Related]

  • 12. A simple technique for assessing the propensity for crystallization of calcium oxalate and brushite in urine from the increment in oxalate or calcium necessary to elicit precipitation.
    Nicar MJ, Hill K, Pak CY.
    Metabolism; 1983 Sep 15; 32(9):906-10. PubMed ID: 6888271
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F, CLU Working Group.
    Arch Ital Urol Androl; 2015 Jul 07; 87(2):105-20. PubMed ID: 26150027
    [Abstract] [Full Text] [Related]

  • 15. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS, Asplin JR, Frick KK, Granja I, Culbertson CD, Ng A, Grynpas MD, Bushinsky DA.
    J Am Soc Nephrol; 2015 Dec 07; 26(12):3001-8. PubMed ID: 25855777
    [Abstract] [Full Text] [Related]

  • 16. Effect of amiloride with or without hydrochlorothiazide on urinary calcium and saturation of calcium salts.
    Leppla D, Browne R, Hill K, Pak CY.
    J Clin Endocrinol Metab; 1983 Nov 07; 57(5):920-4. PubMed ID: 6619267
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Graphic display of urinary risk factors for renal stone formation.
    Pak CY, Skurla C, Harvey J.
    J Urol; 1985 Nov 07; 134(5):867-70. PubMed ID: 4057368
    [Abstract] [Full Text] [Related]

  • 19. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder.
    Coe FL.
    Ann Intern Med; 1977 Oct 07; 87(4):404-10. PubMed ID: 907239
    [Abstract] [Full Text] [Related]

  • 20. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis.
    Coe FL.
    Acta Urol Belg; 1994 Jun 07; 62(2):25-9. PubMed ID: 8037000
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.